Genomic MDT Meetings

In order to support the interpretation of genomic data and its integration within the clinical Multi-Disciplinary Team process a series of genomic advisory boards have been established.

Genomic Rare Disease Advisory Boards (GRDABs) and Genomic Tumour Advisory Boards (GTABs).

These are multi-disciplinary teams who analyse the more complex genomic results which arise from testing for larger numbers of gene abnormalities.

The Boards will act in an advisory capacity, reviewing and providing interpretation of complex genetic testing including large gene panels, specialised services and whole genome sequencing. Output from the GTAB/GRDAB will be fed into the clinical MDT for a final decision in conjunction with clinical information.

Genome Sequencing Review Process